Biodegradable single-phase cohesive hydrogel
US-2024335587-A1 · Oct 10, 2024 · US
US10245282B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10245282-B2 |
| Application number | US-201715796958-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 30, 2017 |
| Priority date | Nov 22, 2013 |
| Publication date | Apr 2, 2019 |
| Grant date | Apr 2, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.
Opening claim text (preview).
The invention claimed is: 1. A method of treating erythemic skin of a human in need thereof, the method comprising topically applying to the erythemic skin of said human in need thereof a composition comprising a therapeutically effective amount of: (a) hydrolyzed algin; (b) escin; (c) Ruscus aculeatus root extract; (d) ammonium glycyrrhizate; (e) Centella asiatica extract; (f) hydrolyzed yeast protein; and (g) Calendula officinalis flower extract. 2. The method of claim 1 , wherein the composition reduces pro-inflamatory cytokine productin in the skin, and wherein the pro-inflammatory cytokine is TNF-a, IL-6, IL-8, IL-10, IL-12 p40, or GM-CSF. 3. The method of claim 1 , further comprising between 80 to 90% by weight of water. 4. The method of claim 1 , wherein said composition comprises: (a) 0.005 to 0.05% by weight of hydrolyzed algin; (b) 0.001 to 0.05% by weight of escin; (c) 0.001 to 0.01% by weight of Ruscus aculeatus root extract; (d) 0.001 to 0.01% by weight of ammonium glycyrrhizate; (e) 0.0005 to 0.005% by weight of Centella asiatica extract; (f) 0.0003 to 0.003% by weight of hydrolyzed yeast protein; and (g) 0.0003 to 0.003% by weight of Calendula officinalis flower extract. 5. The method of claim 1 , wherein the composition further comprises butylene glycol; glycerin; propylene glycol; diazolidinyl urea; PPG-5-ceteth-20; methylparaben; sodium citrate; disodium EDTA; buteth-3; propylparaben; citric acid; sodium benzotriazolyl butylphenol sulfonate; and panthenol. 6. The method of claim 1 , wherein the composition further comprises glycerin; pentylene glycol; glycereth-26; propylene glycol; triethanolamine; acrylates/C10-30 alkyl acrylate crosspolymer; diazolidinyl urea; hydroxy ethylcellulose; sodium polyacrylate; methylparaben; disodium EDTA; butylene glycol; phenoxy ethanol; caprylyl glycol; propylparaben; and panthenol. 7. The method of claim 1 , wherein the composition further comprises pentylene glycol; polysilicone-11; hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer; dimethicone; squalane; glyceryl undecylenate; silica; butylene glycol; triethanolamine; polysorbate 60; acrylates/C10-30 alkyl acrylate crosspolymer; hydroxypropyl cyclodextrin; sorbitan isostearate; panthenol; and glycerin. 8. The method of claim 1 , wherein the composition further comprises glycerin; pentylene glycol; glycereth-26; benzyl alcohol; triethanolamine; acrylates/C10-30 alkyl acrylate crosspolymer; hydroxy ethylcellulose; sodium polyacrylate; di sodium EDTA; hydroxypropyl cyclodextrin; butylene glycol; phenoxy ethanol; caprylyl glycol; and panthenol.
Preparations for sensitive skin · CPC title
Alginic acid; Salts thereof · CPC title
Steroids; Derivatives thereof · CPC title
Cactaceae (Cactus family), e.g. pricklypear or Cereus · CPC title
Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.